These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 21753179)

  • 1. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery P; Pender MP; Burrows JM; Burrows SR; Chapman C; Coulthard A; Dwyer DE; Dwyer T; Kilpatrick T; Lay ML; McMichael AJ; Taylor BV; van der Mei IA; Williams D
    Neurology; 2011 Jul; 77(4):371-9. PubMed ID: 21753179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis.
    Huang J; Tengvall K; Lima IB; Hedström AK; Butt J; Brenner N; Gyllenberg A; Stridh P; Khademi M; Ernberg I; Al Nimer F; Manouchehrinia A; Hillert J; Alfredsson L; Andersen O; Sundström P; Waterboer T; Olsson T; Kockum I
    Brain; 2024 Oct; 147(10):3573-3582. PubMed ID: 38630618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus and multiple sclerosis: interaction with HLA.
    Sundqvist E; Sundström P; Lindén M; Hedström AK; Aloisi F; Hillert J; Kockum I; Alfredsson L; Olsson T
    Genes Immun; 2012 Jan; 13(1):14-20. PubMed ID: 21776012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study.
    Ascherio A; Munger KL; Lennette ET; Spiegelman D; Hernán MA; Olek MJ; Hankinson SE; Hunter DJ
    JAMA; 2001 Dec; 286(24):3083-8. PubMed ID: 11754673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of a first clinical diagnosis of central nervous system demyelination in relation to human herpesviruses in the context of Epstein-Barr virus.
    Lucas RM; Lay MJ; Grant J; Cherbuin N; Toi CS; Dear K; Taylor BV; Dwyer DE; ; Ponsonby AL
    Eur J Neurol; 2023 Sep; 30(9):2752-2760. PubMed ID: 37306550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heightened Epstein-Barr virus immunity and potential cross-reactivities in multiple sclerosis.
    Thomas OG; Haigh TA; Croom-Carter D; Leese A; Van Wijck Y; Douglas MR; Rickinson A; Brooks JM; Taylor GS
    PLoS Pathog; 2024 Jun; 20(6):e1012177. PubMed ID: 38843296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2005 May; 293(20):2496-500. PubMed ID: 15914750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking and Epstein-Barr virus infection in multiple sclerosis development.
    Hedström AK; Huang J; Brenner N; Butt J; Hillert J; Waterboer T; Kockum I; Olsson T; Alfredsson L
    Sci Rep; 2020 Jul; 10(1):10960. PubMed ID: 32620875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples.
    Salzer J; Nyström M; Hallmans G; Stenlund H; Wadell G; Sundström P
    Mult Scler; 2013 Oct; 19(12):1587-91. PubMed ID: 23549431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1).
    Rubicz R; Yolken R; Drigalenko E; Carless MA; Dyer TD; Bauman L; Melton PE; Kent JW; Harley JB; Curran JE; Johnson MP; Cole SA; Almasy L; Moses EK; Dhurandhar NV; Kraig E; Blangero J; Leach CT; Göring HH
    PLoS Genet; 2013; 9(1):e1003147. PubMed ID: 23326239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
    Munger KL; Levin LI; O'Reilly EJ; Falk KI; Ascherio A
    Mult Scler; 2011 Oct; 17(10):1185-93. PubMed ID: 21685232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis.
    De Jager PL; Simon KC; Munger KL; Rioux JD; Hafler DA; Ascherio A
    Neurology; 2008 Mar; 70(13 Pt 2):1113-8. PubMed ID: 18272866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis.
    Wagner HJ; Munger KL; Ascherio A
    Eur J Neurol; 2004 Dec; 11(12):833-4. PubMed ID: 15667414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis and Epstein-Barr virus.
    Levin LI; Munger KL; Rubertone MV; Peck CA; Lennette ET; Spiegelman D; Ascherio A
    JAMA; 2003 Mar; 289(12):1533-6. PubMed ID: 12672770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-barr virus and multiple sclerosis risk in the finnish maternity cohort.
    Munger KL; Hongell K; Cortese M; Åivo J; Soilu-Hänninen M; Surcel HM; Ascherio A
    Ann Neurol; 2019 Sep; 86(3):436-442. PubMed ID: 31226219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to infant siblings during early life and risk of multiple sclerosis.
    Ponsonby AL; van der Mei I; Dwyer T; Blizzard L; Taylor B; Kemp A; Simmons R; Kilpatrick T
    JAMA; 2005 Jan; 293(4):463-9. PubMed ID: 15671431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis of the sero-epidemiological association between Epstein Barr virus and multiple sclerosis.
    Almohmeed YH; Avenell A; Aucott L; Vickers MA
    PLoS One; 2013; 8(4):e61110. PubMed ID: 23585874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.